Spirovant Sciences, Inc.

Spirovant Sciences, Inc. company information, Employees & Contact Information

Spirovant Sciences is developing novel gene therapies for cystic fibrosis and other pulmonary diseases. We are the only company advancing programs with both AAV and lentivirus vectors.

Company Details

Employees
19
Founded
-
Address
3675 Market St,
Phone
+267 244 8206
Email
in****@****ant.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Philadelphia, Pennsylvania
Looking for a particular Spirovant Sciences, Inc. employee's phone or email?

Spirovant Sciences, Inc. Questions

News

Spirovant Sciences doses first subject in cystic fibrosis gene therapy trial - Clinical Trials Arena

Spirovant Sciences doses first subject in cystic fibrosis gene therapy trial Clinical Trials Arena

Spirovant Sciences Doses First Patient in the SAAVe Phase 1/2 Clinical Trial of Its Investigational, Aerosol-Delivered Genetic Medicine for the Treatment of Cystic Fibrosis - PR Newswire

Spirovant Sciences Doses First Patient in the SAAVe Phase 1/2 Clinical Trial of Its Investigational, Aerosol-Delivered Genetic Medicine for the Treatment of Cystic Fibrosis PR Newswire

Spirovant Sciences achieves milestone for experimental cystic fibrosis treatment - The Business Journals

Spirovant Sciences achieves milestone for experimental cystic fibrosis treatment The Business Journals

SP-101 gene therapy shows promise for cystic fibrosis treatment - News-Medical

SP-101 gene therapy shows promise for cystic fibrosis treatment News-Medical

US trial of CF gene therapy SP-101 begins dosing, is still recruiting - Cystic Fibrosis News Today

US trial of CF gene therapy SP-101 begins dosing, is still recruiting Cystic Fibrosis News Today

Roivant, Sumitomo alliance to target cystic fibrosis gene therapy - BioPharma Dive

Roivant, Sumitomo alliance to target cystic fibrosis gene therapy BioPharma Dive

Spirovant Launches State-of-the-Art Laboratory and Headquarters - PR Newswire

Spirovant Launches State-of-the-Art Laboratory and Headquarters PR Newswire

News - Mary Ann Liebert, Inc.

News Mary Ann Liebert, Inc.

The Roivant-Sumitomo Deal: $3 Billion, 5 Companies, $550 Million in Loans and an Option on 6 More Companies - BioSpace

The Roivant-Sumitomo Deal: $3 Billion, 5 Companies, $550 Million in Loans and an Option on 6 More Companies BioSpace

This is Philadelphia’s big life sciences moment - Technical.ly

This is Philadelphia’s big life sciences moment Technical.ly

Sumitomo Dainippon Pharma acquires late stage biopharma companies and forms alliance with Roivant Sciences Ltd. worth $3 billion - Jones Day

Sumitomo Dainippon Pharma acquires late stage biopharma companies and forms alliance with Roivant Sciences Ltd. worth $3 billion Jones Day

After selling off a clutch of Vants, Roivant CEO Ramaswamy moves upstairs to executive chair - Fierce Biotech

After selling off a clutch of Vants, Roivant CEO Ramaswamy moves upstairs to executive chair Fierce Biotech

Sumitovant Biopharma Has a Strong Fourth Quarter with Significant Clinical Development and Corporate Achievements Across its Portfolio of Companies - PR Newswire

Sumitovant Biopharma Has a Strong Fourth Quarter with Significant Clinical Development and Corporate Achievements Across its Portfolio of Companies PR Newswire

Top Spirovant Sciences, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant